Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Adenosine A2a Receptor Kit CLIA

Ce kit ELISA Chemiluminescent est destiné à la mesure quantitative de Humain Adenosine A2a Receptor.
N° du produit ABIN6201458
1.290,21 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 7 à 15 jours ouvrables

Aperçu rapide pour Adenosine A2a Receptor Kit CLIA (ABIN6201458)

Antigène

Voir toutes Adenosine A2a Receptor (ADORA2A) Kits CLIA
Adenosine A2a Receptor (ADORA2A)

Reactivité

  • 7
  • 5
  • 4
  • 1
Humain

Méthode de détection

Chemiluminescent

Type de méthode

Sandwich ELISA

Gamme de detection

0.156 ng/mL - 10 ng/mL

Application

ELISA

Type d'échantillon

Tissue Homogenate
  • Seuil minimal de détection

    0.156 ng/mL

    Fonction

    Human Adenosine A2a Receptor (ADORA2a) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates and other biological fluids.

    Analytical Method

    Quantitative

    Sensibilité

    < 0.06 ng/mL
  • Indications d'application

    Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

    Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

    Standard Form: Lyophilized

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Stock

    4 °C/-20 °C

    Stockage commentaire

    Upon receipt, store the kit according to the storage instruction in the kit's manual.

    Date de péremption

    6 months
  • Antigène Voir toutes Adenosine A2a Receptor (ADORA2A) Kits CLIA

    Adenosine A2a Receptor (ADORA2A)

    Autre désignation

    ADORA2A

    Pathways

    Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!